investors’ rights agreementInvestors’ Rights Agreement • June 23rd, 2023 • Sagimet Biosciences Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJune 23rd, 2023 Company Industry JurisdictionThis Amended and Restated Investors’ Rights Agreement (this “Agreement”) is made as of December 21, 2020, by and among Sagimet Biosciences Inc., a Delaware corporation (the “Company”), and the investors listed on the Schedule of Investors attached as Exhibit A hereto (each, an “Investor,” and collectively, the “Investors”).
investors’ rights agreementInvestors’ Rights Agreement • March 24th, 2023 • Sagimet Biosciences Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 24th, 2023 Company Industry JurisdictionThis Amended and Restated Investors’ Rights Agreement (this “Agreement”) is made as of December 21, 2020, by and among Sagimet Biosciences Inc., a Delaware corporation (the “Company”), and the investors listed on the Schedule of Investors attached as Exhibit A hereto (each, an “Investor,” and collectively, the “Investors”).
investors’ rights agreementInvestors’ Rights Agreement • April 16th, 2021 • Sagimet Biosciences Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledApril 16th, 2021 Company Industry JurisdictionThis Amended and Restated Investors’ Rights Agreement (this “Agreement”) is made as of December 21, 2020, by and among Sagimet Biosciences Inc., a Delaware corporation (the “Company”), and the investors listed on the Schedule of Investors attached as Exhibit A hereto (each, an “Investor,” and collectively, the “Investors”).